These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 17512770

  • 1. Growth hormone response to low-dose apomorphine in restless legs syndrome.
    Happe S, Bachmann CG, Helmschmied K, Neubert K, Wuttke W, Paulus W, Trenkwalder C.
    Growth Horm IGF Res; 2007 Aug; 17(4):323-7. PubMed ID: 17512770
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC, Dahmen MM, Makos M, Lea JW, Carver LJ, Rasu RS.
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Appropriate use of dopamine agonists and levodopa in restless legs syndrome in an ambulatory care setting.
    Molokwu OC.
    Ann Pharmacother; 2008 May; 42(5):627-32. PubMed ID: 18381842
    [Abstract] [Full Text] [Related]

  • 9. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels.
    Frauscher B, Gschliesser V, Brandauer E, El-Demerdash E, Kaneider M, Rücker L, Poewe W, Högl B.
    Sleep Med; 2009 Jun; 10(6):611-5. PubMed ID: 19200780
    [Abstract] [Full Text] [Related]

  • 10. Changes of cortical excitability after dopaminergic treatment in restless legs syndrome.
    Scalise A, Pittaro-Cadore I, Janes F, Marinig R, Gigli GL.
    Sleep Med; 2010 Jan; 11(1):75-81. PubMed ID: 19595629
    [Abstract] [Full Text] [Related]

  • 11. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome.
    García-Borreguero D, Kohnen R, Högl B, Ferini-Strambi L, Hadjigeorgiou GM, Hornyak M, de Weerd AW, Happe S, Stiasny-Kolster K, Gschliesser V, Egatz R, Cabrero B, Frauscher B, Trenkwalder C, Hening WA, Allen RP.
    Sleep Med; 2007 Aug; 8(5):455-63. PubMed ID: 17543579
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
    Giorgi L, Ritchie SY, Kirsch JM.
    Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
    [Abstract] [Full Text] [Related]

  • 15. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome.
    Stiasny-Kolster K, Magerl W, Oertel WH, Möller JC, Treede RD.
    Brain; 2004 Apr; 127(Pt 4):773-82. PubMed ID: 14985260
    [Abstract] [Full Text] [Related]

  • 16. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment.
    Kallweit U, Siccoli MM, Poryazova R, Werth E, Bassetti CL.
    Eur Neurol; 2009 Apr; 62(3):176-9. PubMed ID: 19602890
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dopamine agonists restore cortical plasticity in patients with idiopathic restless legs syndrome.
    Rizzo V, Aricò I, Mastroeni C, Morgante F, Liotta G, Girlanda P, Silvestri R, Quartarone A.
    Mov Disord; 2009 Apr 15; 24(5):710-5. PubMed ID: 19117337
    [Abstract] [Full Text] [Related]

  • 19. Low-dose hydrocortisone in the evening modulates symptom severity in restless legs syndrome.
    Hornyak M, Rupp A, Riemann D, Feige B, Berger M, Voderholzer U.
    Neurology; 2008 Apr 29; 70(18):1620-2. PubMed ID: 18443313
    [Abstract] [Full Text] [Related]

  • 20. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
    Allen RP, Ritchie SY.
    Sleep Med; 2008 Dec 29; 9(8):899-902. PubMed ID: 18024167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.